New Study Explores Umbilical Cord Tissue Allografts for Chronic Back Muscle and Tendon Pain
A newly published observational study followed 117 patients who received cryopreserved umbilical cord tissue injections for stubborn muscle and tendon damage near the spine. Here is what the early data actually shows, and how it fits alongside other non-surgical options already making news this year.
Key takeaways
- A newly published observational study followed 117 patients across 11 clinics who received a cryopreserved umbilical cord tissue allograft for muscle and tendon damage near the thoracic and lumbar spine.
- Patients who returned for a second or third application generally ended up with the lowest reported pain scores, and researchers described those improvements as statistically meaningful.
- This approach targets paraspinal muscle and enthesis damage specifically, a different focus than disc-centered therapies like PRP, stem cell injections, or ozone-oxygen discectomy that have made headlines this year.
- The findings come from an observational registry, not a randomized trial, so they are an early signal worth watching rather than proof the treatment works for everyone; nothing here is medical advice or a guarantee of results.
Figures drawn from an observational study published in Biomedicines, July 2026, covering cryopreserved umbilical cord tissue allografts for paraspinal muscle and tendon damage.
A regenerative option built from donated tissue, not a patient's own cells
A study recently published in the peer-reviewed journal Biomedicines is drawing attention from spine researchers for an approach that differs from the platelet-rich plasma and stem cell therapies that have already made news this year. Instead of using a patient's own blood or bone marrow, this treatment relies on a cryopreserved human umbilical cord tissue allograft, sometimes called a Wharton's jelly allograft, made from donated tissue processed by an FDA-registered tissue bank.
The 117 patients who took part all had imaging that confirmed degeneration in their paraspinal muscles or in the entheses, the points where a tendon or muscle attaches to bone. That is a source of chronic back and upper-body pain that does not always show up as a classic herniated disc, which is part of why researchers wanted to study it separately.
Care was delivered across eleven clinics, with patients receiving one, two, or three separate applications of the allograft depending on how their case was assessed. The tissue itself functions as an injectable scaffold meant to support the body's own soft-tissue repair process rather than replace or remove anything surgically.
What the pain and function scores actually showed
Researchers tracked two standard measurement tools before and after treatment: the Numeric Pain Rating Scale, a simple zero-to-ten pain rating, and the WOMAC index, which combines pain, stiffness, and daily function into one score. Every group in the study, whether patients received one, two, or three applications, reported lower average scores on both measures after treatment than before it.
The clearest pattern in the data was tied to how many applications a patient received. Those who came back for a second or third round, typically because their case needed more attention, ended up with the lowest final pain scores of the three groups, and the study's authors described those particular improvements as statistically significant. Patients who received just one application also improved, though generally by a smaller margin.
Notably for a therapy this new, the study's authors reported that none of the participants experienced complications tied to the injections during the observation period. Still, this was an observational registry rather than a blinded, controlled trial, so it points to a pattern worth following rather than settled proof of how well the therapy works or for whom.
Where this fits among other back-pain research making news
This is far from the only regenerative approach in the headlines this year. Platelet-rich plasma, stem cell injections, and ozone-oxygen disc therapy have each had their own research cycles recently, and each one targets a slightly different part of the problem, whether that is a bulging disc, an inflamed joint, or damaged soft tissue around the spine. An umbilical cord tissue allograft is being studied specifically for muscle and enthesis damage rather than the disc itself, which is part of what sets this new data apart.
None of these approaches are positioned as a replacement for a thorough evaluation, and none of them help every type of back or neck pain. What is actually driving a person's discomfort, whether that is a disc, a joint, a muscle, a tendon attachment, or some combination, still changes what is likely to help, which is why imaging and a hands-on exam matter more than any single new therapy in the news.
What this could mean if the basics haven't worked for you
If you have already tried rest, over-the-counter medication, or a round of physical therapy and stubborn back or upper-body pain still hasn't let up, research like this is a reminder that the non-surgical toolbox keeps growing. That does not mean this particular therapy, or any single treatment, is the right fit without a proper look at what is actually causing your pain.
This article is meant to inform, not to diagnose any condition or promise a specific result for any individual. If chronic back, neck, or upper-body pain has been slowing you down, talking it through with a qualified provider is still the sensible next step, and our team at Las Vegas Spine & Disc is happy to walk through what your non-surgical options might look like.
Where Regenerative and Non-Surgical Therapies Fit in the Back-Pain Toolbox
New research keeps expanding the non-surgical options clinicians can discuss with patients. Here is a general overview of where several current approaches, including this new one, tend to fit.
- Movement and physical therapy: Guided exercise and structured movement remain a foundation for most chronic back pain plans and are typically tried before more invasive options.
- Platelet-rich plasma (PRP): Uses a concentration of a patient's own blood platelets, often studied for disc-related and joint conditions.
- Ozone-oxygen disc injections: An investigational approach being studied in FDA trials for contained disc herniations that haven't responded to conservative care.
- Stem cell injections: Being evaluated in later-stage trials for chronic low back pain tied to disc degeneration.
- Umbilical cord tissue allografts: The subject of the new study above, aimed specifically at damaged paraspinal muscle and tendon attachment points rather than the disc itself.
- Epidural steroid injections: Deliver anti-inflammatory medication near an irritated nerve root, sometimes used to help patients tolerate active rehab.
- Radiofrequency ablation: Uses targeted heat to interrupt specific pain signals and is considered for certain persistent facet-related pain.
- Surgery: Generally reserved for cases with clear structural problems that haven't improved with non-surgical care.
Frequently Asked Questions
What is a Wharton's jelly or umbilical cord tissue allograft?
It is donated umbilical cord tissue that has been cleaned, processed, and cryopreserved by a tissue bank, then used as an injectable scaffold meant to support the body's own soft-tissue repair process. It does not use a patient's own blood or cells, which sets it apart from PRP or some stem cell approaches.
Is this treatment FDA-approved specifically for back pain?
The tissue is manufactured by an FDA-registered tissue bank, which is different from having a specific FDA approval for a back-pain indication. The recent findings come from an observational study rather than the kind of large randomized trial typically used to support a treatment-specific approval, so more research is still needed.
Does this replace physical therapy or surgery?
No. Researchers describe it as one option within a broader toolbox that still includes movement-based therapy, medication, injections, and, for some patients, surgery. Nothing in this early study suggests it should replace a full evaluation or a personalized care plan.
Can I ask about non-surgical options like this at Las Vegas Spine & Disc?
Yes. If chronic back or upper-body pain hasn't responded to the basics, our team can walk you through non-surgical options that may fit your situation, informed by current research, without guaranteeing any particular result.
Sources
- New Research Shows Positive Clinical Outcomes With Thoracic & Lumbar Spinal Patients — PR Newswire
- Biologic treatment shows promise for spinal degeneration — Becker's Spine Review